Company

Anixa Biosciences Inc

ANIX · CIK 0000715446

SEC FORM 4

$15,620.00

Purchase of 5,500 shares at $2.84 per share.

Reporting Person Catelani Michael · Officer Title President, COO, & CFO · Transaction Code P

Traded Sep 30, 2026 · Disclosed Sep 30, 2026

Source: SEC Form 4 · 0001493152-26-045053 · filed 2026-09-30 · View filing →

SEC FORM 4CLUSTER · 3 INSIDERS

$165,166.84

Purchase of 61,036 shares across 3 reporting persons.

Transaction Code P · Reporting Persons 3

Titterton Lewis H jrPurchase of 49,036 shares at $2.69 per share.$131,906.84
Baskies Arnold MPurchase of 5,000 shares at $2.76 per share.$13,800.00
KUMAR AMIT, Chief Executive OfficerPurchase of 7,000 shares at $2.78 per share.$19,460.00

Surfaced by rule: 3 distinct insiders, open-market purchases, 7-day window — a deterministic filter, not a recommendation.

Traded Sep 23, 2026 · Disclosed Sep 28, 2026FILED +5 DAYS

Source: SEC Form 4 · 0001493152-26-044250 · filed 2026-09-25 · View filing →

Source: SEC Form 4 · 0001493152-26-044457 · filed 2026-09-28 · View filing →

Source: SEC Form 4 · 0001493152-26-044458 · filed 2026-09-28 · View filing →

SEC FORM 4CLUSTER · 2 INSIDERS

$49,350.00

Purchase of 18,000 shares across 2 reporting persons.

Transaction Code P · Reporting Persons 2

KUMAR AMIT, Chief Executive OfficerPurchase of 5,000 shares at $2.76 per share.$13,800.00
Titterton Lewis H jrPurchase of 10,000 shares at $2.73 per share.$27,300.00
KUMAR AMIT, Chief Executive OfficerPurchase of 3,000 shares at $2.75 per share.$8,250.00

Surfaced by rule: 2 distinct insiders, open-market purchases, 7-day window — a deterministic filter, not a recommendation.

Traded Sep 10, 2026 · Disclosed Sep 14, 2026

Source: SEC Form 4 · 0001493152-26-042302 · filed 2026-09-11 · View filing →

Source: SEC Form 4 · 0001493152-26-042502 · filed 2026-09-14 · View filing →

Source: SEC Form 4 · 0001493152-26-042512 · filed 2026-09-14 · View filing →